This review addresses the rationale for left ventriculoplasty, presents the prior surgical and percutaneous attempts in the field, provides an overview of the novel transcatheter left ventriculoplasty devices and their respective trials, and highlights potential challenges associated with establishing such device-based therapies in the armamentarium against heart failure. #EIJBestOf https://ow.ly/yt8t50QEo07
EuroIntervention’s Post
More Relevant Posts
-
The TAVI-SMALL 2 registry study explored the use of different transcatheter heart valves in patients with small aortic annuli. It compared the hemodynamic performance and clinical outcomes between self-expanding and balloon-expandable valves. The study found that self-expanding valves, particularly when placed supra-annularly, generally provided better hemodynamic results and lower rates of prosthesis-patient mismatch, although with a higher incidence of paravalvular leaks. #EIJBestOf Azeem Latib Pier Pasquale Leone http://ow.ly/4cXy50NF4X7
To view or add a comment, sign in
-
-
Novel 3D whole-heart BOOST CMR sequence is easy to use for a wide range of patients and is suitable for visualizing the pulmonary veins in patients with atrial fibrillation. (Zsófia Dohy et al.) #EuropeanRadiology 🔗 https://buff.ly/3Rdquiy
To view or add a comment, sign in
-
-
May is #SkinCancerAwarenessMonth. Xstrahl is focused on expanding treatment options for all who suffer from #SkinCancer. When it comes to #NMSC, we are proud to offer innovative treatment options with #RadiantAura. Curative treatment of #NMSC is broadly divided into surgical excision (which accounts for most cases), radiation therapy, and other treatments. See how radiation therapy compares to other treatment options: https://lnkd.in/eAGHP2dc
To view or add a comment, sign in
-
-
In a trial of 60 patients with Bothrops snakebites, low-level laser therapy (LLLT) combined with antivenom decreased pain intensity scores, extent of edema, and extremity circumference (as compared to the contralateral limb) compared with antivenom alone. LLLT is a promising adjunct to antivenom for local tissue damage from snake envenoming, but more trials and access to equipment are needed before it can be recommended for routine use. Check out What's New in #EmergencyMedicine: https://ow.ly/atjp50QxS1q #ClinicalUpdates #MedEd
To view or add a comment, sign in
-
-
Clinical testing of the first implantable device combining cardiac contractility modulation with cardioversion/defibrillation is underway: https://cle.clinic/3PjlPcC
To view or add a comment, sign in
-
-
Congratulations to Johnson & Johnson for Shockwave obtention. I share my first Shockwave case here In 2020 at Institute Arnault Tzanck A 49 years old patient with an inferior myocardial infarction involving an acute occlusion of the right coronary artery. Percutaneous coronary intervention was complicated by balloon’s stent rupture and stent under-deployment into a calcification seen in stent boost enhancement. After failed attempts to post dilate the under deployed stent with: - non-compliant - super high pressure - and cutting balloons --> Shockwave balloon which corrected the stent under deployment after 20 therapies delivered only. This case reports highlights the importance to have Shockwave technology available in heart catheterization laboratory. #Shockwave #Institutarnaulttzanck #JohnsonandJohnson #cardioetvous #ECC_Congres #CongresACTIF #GRCICardio
To view or add a comment, sign in
-
-
The #SMARTtrial data makes a difference for women. With its focus on patients with small annuli, 87% of those enrolled in this late-breaking trial were women. Explore how the Evolut™ #TAVR valve design delivers superior outcomes for women with small annuli vs. SAPIEN platform at 1 year¹: https://bit.ly/4eb8a31 Risk Info: https://bit.ly/4aKlCI1 TAVR risks may include, but are not limited to, death, stroke, damage to the arteries, bleeding, and need for permanent pacemaker. 1. Herrmann H, et al. Self-expanding Versus Balloon-expandable Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annuli: Primary Outcomes From the Randomized SMART Trial. Presented at ACC: April 2024.
To view or add a comment, sign in
-
Thermedical Successfully Completes Feasibility Study for Treating Cardiac Arrhythmias Using Pulsed Field Ablation in Combination with SERF Ablation WESTON, Mass.--(BUSINESS WIRE)-- #Durablate--Thermedical®, a developer of advanced thermal-ablation systems to treat ventricular arrhythmias, announced today that it has completed a feasibility study utilizing Pulsed Field Ablation (PFA) therapy in combination with its SERF Ablation System and Durablate® Catheter for treating ventricular tachycardia (VT). VT is an abnormally rapid heart rhythm that is a leading cause of sudden cardiac death worldwide. via Business Wire Health: Medical Devices News April 23, 2024 at 04:01PM
To view or add a comment, sign in
-
📢 Revolutionize fibroid treatment with our cutting-edge embolization technique at Premier Med Egészségközpont, designed to preserve the uterus while minimizing patient and physician radiation exposure. This minimally invasive procedure, led by Dr. Zoltán Harmat, who has successfully performed nearly 2000 fibroid embolizations, utilizes a straightforward catheter insertion to deliver PVA particles. These particles block the fibroids' blood supply, causing shrinkage and death, all within 30-40 minutes and with minimal risk. The procedure's advantages include significantly reduced radiation exposure, thanks to Kinepict technology, and color-coded video monitoring, enhancing the ability to track the embolization's success in real time. ⏱️ #FibroidEmbolization #MinimallyInvasive #InnovativeHealthcare #PremierMed #LowRadiation
To view or add a comment, sign in
-
-
Hip labral width <6.1 mm at the 11:30 position correlates with a higher rate of arthroscopic revision but not conversion to THA at 5 years. Despite this difference, patients with small labrums achieved MCID at comparable rates. https://ow.ly/X4Xw50SmvI2
To view or add a comment, sign in
-